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DObjectives: The use of thoracic endovascular aortic repair (TEVAR) for chronic DeBakey III type b (CDIIIb)
aneurysms is controversial. We analyzed the potential prognostic factors affecting aorta remodeling after this
procedure.
Methods:A total of 20 patients with CDIIIb aneurysms underwent TEVAR, with full coverage of reentry tears at
the descending thoracic aorta. The potential factors affecting false lumen (FL) remodeling were analyzed,
including reentry tears (communicating channels visible on the computed tomography angiogram), large intimal
tears below the stent graft (2 consecutive axial cuts on the computed tomography angiogram), visceral
branches arising from the FL, and intercostal arteries (ICAs) arising from the FL.
Results:All the patients had uneventful in-hospital courses; 2 patients (10%) required reintervention during the
follow-up period. Thirteen patients (65%) had complete thrombosis of the FL at stent graft segment. Compared
with the complete thrombosis group, the partial thrombosis group had more reentry tears (1.8 vs 2.3, P ¼ .48),
large intimal tears (0.8 vs 1.7, P<.05), visceral branches arising from the FL (1.2 vs 2.3, P<.05), and ICAs
arising from the FL (3.8 vs 5.1, P¼ .35). Reentry tears, visceral branches, and ICAs from the FL were significant
negative prognostic factors for FL shrinkage (P<.05).
Conclusions: Although reentry tears above the celiac trunk were fully covered, the visceral branches and ICAs
from the FL and all communicating channels below the celiac trunk kept the FL pressurized and were unfavor-
able prognostic factors for aorta remodeling after TEVAR for CDIIIb aneurysms. (J Thorac Cardiovasc Surg
2014;148:925-33)Supplemental material is available online.The ideal treatment of patients with chronic DeBakey III
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The Journal of Thoracic and Casuch as those involving aneurysmal degeneration, malper-
fusion, persistent pain, or rupture. Although recent series
have suggested thoracic endovascular aortic repair (TE-
VAR) as a promising treatment of acute, complicated type
B aortic dissections,1,2 outcome studies of TEVAR-treated
CDIII aneurysms have been primarily retrospective,
single-center experiences involving heterogeneous
cohorts with various operative indications and different
strategies.
Open surgery for CDIII aneurysms has been associated
with substantial morbidity and mortality.3,4 In light of the
success of TEVAR in patients with degenerative
aneurysms, this therapy offers an attractive alternative to
open surgery for CDIII aneurysms.5,6 However, several
issues also mitigate against the use of TEVAR in these
patients. The presence of a mature, rigid dissection flap,
and multiple reentry tears have been thought to potentiate
failure of endovascular therapy, and the long-term dura-
bility of endovascular management remains uncertain.7
The primary aim of managing CDIII aneurysms is to
avoid death from aortic rupture. This clinical endpoint has
frequently been associated with the ability of TEVAR to
trigger favorable aortic remodeling, an important outcome
predictor of false lumen (FL) patency.8,9
Although the results of TEVAR for CDIII type a (CDIIIa)
aneurysms have been exciting, concerns regarding the userdiovascular Surgery c Volume 148, Number 3 925
Abbreviations and Acronyms
CDIII ¼ chronic DeBakey III
CDIIIa ¼ chronic DeBakey III type a
CDIIIb ¼ chronic DeBakey III type b
CTA ¼ computed tomography angiogram
FL ¼ false lumen
ICA ¼ intercostal artery
SCI ¼ spinal cord ischemia
TEVAR ¼ thoracic endovascular aortic repair
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Dof this technique in patients with CDIII type b (CDIIIb) an-
eurysms remain, including concerns about the precipitation
of retrograde dissection or visceral ischemia.10,11
The present study investigated the prognostic factors for
aorta remodeling after TEVAR for complicated CDIIIb
aneurysms.METHODS
Patient Population
The institutional review board at the Gangnam Severance Hospital,
Yonsei University College of Medicine (Yonsei institutional review board
no. 3-2012-0259) approved the present study. A prospectively maintained
endovascular aortic registry was queried for all patients undergoing TE-
VAR from May 2012 to April 2013.
Patients treated for degenerative and trauma-related pathologic entities
(including aneurysms, penetrating ulcers, atheromatous disease, pseudoa-
neurysms, and traumatic transections) were excluded. Patients with
dissection-related indications were reviewed further, and only those under-
going elective procedures for chronic (>3months after the diagnosis of acute
aortic dissection) aneurysmal degeneration of descending aortic dissections
extending to the abdominal aorta (CDIIIb) were included. The patients with
dissecting aneurysms confined to the descending thoracic aorta (CDIIIa)
were excluded. Although acute proximal dissections were not included, pa-
tients previously treated for type A dissections who had residual CDIIIb an-
eurysms were included. The indications for TEVAR included newly
developed, continuing back pain, and aneurysmal degeneration (maximal
thoracic aneurysm diameter  5.5 cm or a documented growth rate of 0.5
cm within 6 months seen on serial computed tomography angiograms
[CTA]). The demographics, comorbidities, procedure-specific details, rein-
terventions, and complications were collected from the medical records.
Clinical Practice
A standardized treatment algorithm was used throughout the study
period for patient selection and procedural conduct. All operations were
performed electively with the patient under general anesthesia in a hybrid
operating room. The need for perioperative adjuncts (eg, spinal drainage,
carotid–subclavian bypass, open or percutaneous vessel access) were at
the discretion of the attending surgeon and interventional radiologist.
All patients received systemic heparin (100 U/kg) to achieve an acti-
vated clotting time of more than 300 seconds. Devices were oversized
10% to 15%, relative to the diameter of the undissected aorta proximal
to the dissection, using tapered stent grafts. At the beginning of study
period, the distal landing zone was in the mid-descending thoracic aorta
(group 3). However, for the remaining cases, the coverage length was
selected to exclude the entire dissected thoracic aorta and all fenestrations
(group 2). Our current practice has been for more aggressive aortic
coverage (ie, we generally treat down to the celiac artery in patients with
juxtaceliac fenestrations (group 1; Figure 1). In some cases, we have926 The Journal of Thoracic and Cardiovascular Surgcovered the celiac trunk, when backflow from the superior mesenteric ar-
tery was expected. Technical success was defined as endograft deployment
at the intended aortic segment, with the absence of antegrade flow into the
FL. Compliant balloon angioplasty of the proximal stent graft was selec-
tively performed only in the event of type Ia endoleaks. Spinal cord
ischemia (SCI) was defined as any new lower extremity motor and/or sen-
sory deficit not attributable to intracranial pathologic features, peripheral
neuropathy, or neuropraxia. The diagnosis was determined by the treating
physician and confirmatory imaging.
Degree of FL Thrombosis
Thedegree ofFL thrombosiswas analyzedusingprecontrast, arterial, and
delayed phases of postoperative CTA (3-mm-thick axial slices). It was clas-
sified as partial thrombosis if both flow and thrombus were present and as
complete thrombosis if no flow was present at the level of the stent graft.12
Remodeling Analysis
Aorta remodeling after TEVAR was analyzed, as shown in Figure E1.
The preoperative FL diameter was marked as ‘‘a,’’ and the postoperative
FL diameter was marked as ‘‘b.’’ The measurements of ‘‘a’’ and ‘‘b’’
were performed at the level of the maximal descending thoracic aortic
aneurysm. We sought to find risk factors affecting the FL ratio (b/a). If
>2 CT scans had been performed after hospital discharge, the most recent
image was used to determine the ratio. If an aortic segment had been sub-
jected to repeated aortic procedures, the patient was excluded from addi-
tional FL diameter assessments. Postoperative surveillance was
determined using a protocol of imaging before discharge, at 3 and 6months
after discharge, and annually thereafter. We also analyzed the relationship
of the degree of FL thrombosis with the FL ratio.
Anatomic Factors
The maximum diameters of the thoracic aorta, thoracic FL, abdominal
aorta, and abdominal FLs were measured on the preoperative CTAs. The
following parameters weremeasured during postoperative CTAs before pa-
tient discharge by 2 experienced vascular radiologists: residual reentry
tears were counted below the stent graft; large intimal tears were counted,
as seen in 2 CTA axial cuts below the stent graft; the numbers of inter-
costal arteries (ICAs) and visceral arteries from the FL were counted;
and the maximum diameters of the FLs were determined at the last
follow-up CTAs.
Statistical Analysis
The categorical variables were summarized using frequencies and per-
centages. Continuous variables were analyzed using the mean and standard
deviations, if they were normally distributed. Comparisons of patient- or
procedure-related characteristics in subgroup analyses were performed us-
ing Fisher’s exact tests or independent t tests. Variables with P<.1 on uni-
variate analysis were included in the multivariate model, which was refined
using stepwise backward binary logistic regression. The relationship be-
tween the FL ratios and patient variables was analyzed using Spearman’s
rank correlation and linear regression analysis. All statistical analyses
were performed using the Statistical Package for Social Sciences, version
20, software (SPSS, Chicago, Ill).RESULTS
The Gangnam Severance TEVAR registry (n ¼ 103)
identified 20 patients (19%), who had undergone elective
TEVAR for the treatment of CDIIIb aneurysms from May
2012 to April 2013. The mean interval from the diagnosis
of the acute dissection to TEVAR was 18.1  11.9 months
(range, 4-47). Most patients were men (n¼ 17 [85%]; meanery c September 2014
FIGURE 1. Schematic diagram of anatomic factors affecting false lumens after thoracic endovascular aortic repair. Groups were classified according to the
distal landing zone: group I, covered to the celiac trunk; group II, whole descending thoracic aorta; group III, mid-descending thoracic aorta. I, Intercostal
artery from the false lumen; D, diaphragm; L, large intimal tear; R, reentry tear; V, visceral branch from the false lumen.
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Dage, 50.2 years), and the mean follow-up duration was 10.3
 4.9 months (range, 5-15). Ten patients (50%) who had
undergone surgery for acute type A dissections had large
tears at the proximal descending thoracic aorta because
they had had retrograde type A dissections or multiple tears.Procedural Details and Perioperative Outcomes
A total of 30 stent grafts were deployed in 20 patients,
including the Zenith TX2 Proform (Cook, Bloomington,
Ind) in 17 patients and theValiant Captivia (Medtronic,Min-
neapolis, Minn) in 3 patients. Eleven patients (55%) needed
1 stent graft, 8 (40%) needed 2, and 1 (5%) needed 3.
Primary technical success, defined as the successful
closure of the primary tear without a type Ia endoleak,
was achieved in all cases. None of the patients required con-
version to open surgery. Preoperatively placed spinal drains
were used in 13 patients (65%).
In 11 patients (55%), coverage occurred at Ishimaru
zones 1 or 2,13 and all these patients underwent subclavian
revascularization with or without a carotid–carotid bypass.
The distal landing zone was group 1 or 2 in almost all pa-
tients (n ¼ 18, 90%; Figure 1). All patients were treated
with covered stent grafts. The mean hospital and intensive
care unit stay was 7.5 days and 28.7 hours, respectively,
without any in-hospital deaths or neurologic dysfunction.
Additional details regarding the outcomes and complica-
tions are listed in Table 1.The Journal of Thoracic and CaDegree of FL Thrombosis
Thirteen patients (65%) had complete thrombosis of the
FL during the first postoperative CTA performed a mean
of 28 days after TEVAR. Univariate analysis was used to
evaluate the 14 parameters listed in Table 2. Values of
P<.1 were obtained for age at the interventional procedure,
number of large intimal tears, number of visceral branches
partially or totally arising from the FL, and maximum diam-
eter of the aorta and the FL on the abdominal aorta; these
were used in the multivariate analysis. Multivariate binary
logistic regression analysis revealed that the number of large
intimal tears (odds ratio, 11.30; 95% confidence interval,
1.16-110.40; P ¼ .037) was an independent risk factor for
partial thrombosis. When we focused on the anatomic char-
acteristics of the dissections and compared them with those
of the partial thrombosis group, the number of reentry tears,
large intimal tears below the stent graft, visceral branches
arising from the FL, and ICAs arising from the FL in the
complete thrombosis group was 1.8 versus 2.3 (P ¼ .48),
0.8 versus 1.7 (P<.05), 1.2 versus 2.3 (P<.05), and 3.8
versus 5.1 (P ¼ .35), respectively (Table 2).Remodeling Analysis
Remodeling analysis was performed with the FL ratio us-
ing the preoperative CTA and last CTA (4.7 months after
TEVAR). Univariate linear regression analysis revealed
that age, number of reentry tears, visceral branches andrdiovascular Surgery c Volume 148, Number 3 927
TABLE 1. Preoperative, operative, and postoperative outcomes
Variable Value
Preoperative factors 20 (100)
Male gender 17 (85)
Age (y) 50  11
Interval between diagnosis and TEVAR (mo) 18  12
Comorbidities
HTN 18 (90)
DM 1 (5)
Tobacco use 14 (70)
Obesity 14 (70)
Marfan syndrome 1 (5)
CVA 0
CAOD 1 (5)
Previous aortic surgery
Ascending aorta replacement 3 (15)
Hemiarch replacement 1 (5)
Total arch replacement 5 (25)
Descending aorta replacement 1 (5)
Operative details
Preoperative aneurysm diameter (mm) 52  11
Stent graft type
Cook TX2 Proform* 17 (85)
Medtronic Valiant Captiviay 3 (15)
Procedure details
Cerebrospinal drainage 13 (65)
Proximal landing zone
1 4 (20)
2 7 (35)
3 5 (25)
4 4 (20)
Distal landing zone
I 8 (40)
II 10 (50)
III 2 (10)
Clinical outcomes and complications
LOS (d) 7.5  5.6
ICU stay (h) 28.7  14.7
Mortality (%) 0
Complications (n)
Spinal cord ischemia 0
Stroke 0
Pulmonary 0
Cardiac 0
Renal 0
Gastrointestinal 0
Access vessel 1 (5)
Bleeding (bypass vessel) 1 (5)
Endoleak
Ia 0
II 2 (10)
Reintervention 2 (10)
Data are presented as n (%) or mean  standard deviation, unless otherwise noted.
TEVAR, Thoracic endovascular aortic repair; HTN, hypertension; DM, diabetes mel-
litus; CVA, cerebrovascular accident; CAOD, coronary artery occlusive disease; LOS,
length of stay; ICU, intensive care unit. *Cook, Bloomington, Ind. yMedtronic,
Minneapolis, Minn.
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were significant negative prognostic factors predicting FL
shrinkage (P<.05). Multivariate linear regression analysis
revealed that age (P ¼ .015) and the number of visceral
branches and ICAs from the FL (P ¼ .002) were indepen-
dent risk factors for FL shrinkage (Table 3; Figure 2). The
FL ratio of the complete thrombosis group was significantly
lower than that of the partial thrombosis group. (0.70 0.14
vs 0.82  0.07, P ¼ .035; Table 2). The difference in the
shrinkage of the descending thoracic aorta, abdominal
aorta, and abdominal FL was not significant (P>.05).
Reintervention
Reintervention was defined as any aortic-related endo-
vascular or open surgical procedure that occurred after the
index TEVAR at either the intended treatment zone or
remote aortic sites. Two patients (10%; group 3;
Figure 2), at the beginning of the present study, had experi-
enced stent graft-induced new intimal tears at 5 months and
1 year after TEVAR, respectively, and had undergone addi-
tional TEVAR.
DISCUSSION
The aim of postaortic dissection TEVAR is to cover the
primary entry tear, thereby initiating FL thrombosis and
aortic remodeling. Although inconclusive, mounting
evidence has suggested that aortic remodeling is signifi-
cantly associated with improved midterm survival and
that persistent FL perfusion is associated with disease
progression.14-16
Favorable aortic remodeling usually begins within days
after TEVAR for acute aortic dissection and continues for
5 years.17 However, patients with CDIII aneurysms have
greater variations in the rate of complete FL thrombosis.14
Several explanations have been proposed for this variation.
First, according to the current definition, ‘‘chronic’’ dissec-
tions include those that have been present for>2 weeks,
creating significant diversity among individuals within the
classification. The INvestigation of STEnt Grafts in Aortic
Dissection trial, reporting a total FL thrombosis rate of
92.6% at 1 year, enrolled patients at a median of 3.5 weeks
after the diagnosis of acute aortic dissection.2 In contrast,
the study with the lowest rate of FL thrombosis (39%)
treated patients at a mean of 100 weeks after diagnosis,18
even after 3 years of follow-up. The difference between
these 2 studies suggests the classification of aortic dissec-
tions as ‘‘acute’’ or ‘‘chronic’’ is insufficient; the ‘‘sub-
acute’’ classification described in the VIRTUE study (2-4
weeks after the acute event) might be more clinically rele-
vant.19 In our study, we defined ‘‘chronic’’ as>3 months
after the diagnosis of acute aortic dissection.20 Second,
many reports have described data using mixed populations928 The Journal of Thoracic and Cardiovascular Surgery c September 2014
TABLE 2. Risk factors for partial thrombosis in the false lumen after TEVAR
Variable
Complete thrombosis
(n ¼ 13, 65%)
Partial thrombosis
(n ¼ 7, 35%) P value
Multivariate analysis
OR 95% CI P value
Age (y) 53.5  7.8 44.0  7.8 .018
Male gender 11 6 .730
HTN 11 7 .411
Smoking 9 5 .664
Obesity 10 4 .336
Reentry 1.8  1.7 2.3  1.1 .479
Large intimal tear 0.8  0.6 1.7  0.8 .007 11.30 1.16-110.40 .037
Visceral branches from FL 1.2  0.8 2.3  1.0 .019
ICAs from FL 3.8  2.7 5.1  3.6 .346
Visceral þ ICA from FL 5.0  2.9 7.4  3.4 .107
PreMax on Ab (mm)
Aorta 34.0  4.8 39.4  6.2 .072
FL 19.1  9.8 27.1  4.2 .019
PreMax on D (mm)
Aorta 47.9  7.2 51.1  9.2 .406
FL 32.4  10.3 36.1  7.6 .416
FL ratio 0.70  0.14 0.82  0.07 .035
Data presented as n or mean  standard deviation. OR, Odds ratio; CI, confidence interval; HTN, hypertension; FL, false lumen; ICA, intercostal artery; PreMax, preoperative
maximal diameter; Ab, abdominal aorta; D, descending thoracic aorta.
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aneurysms, involving persistent distal FL perfusion, aorta
remodeling has been more difficult than in CDIIIa aneu-
rysms. Rodriguez and colleagues8 reported complete
thrombosis of the thoracic FL in 64% of CDIIIa aneurysms
and 45% of CDIIIb aneurysms after TEVAR. We only
enrolled patients with CDIIIb aneurysms. Third, periopera-
tive practices can change over time or among centers.21,22TABLE 3. Prognostic factors associated with false lumen ratio
Variable
Univariate Multivariate
P value B* 95% CI P value
Age (y) .039 0.508 0.013 to 0.002 .015
Male gender .081
HTN .729
Smoking .134
Obesity .570
Reentry .037
Large intimal tear .229
Visceral branches
from FL
.438
ICAs from FL .008
Visceral þ ICA
from FL
.005 0.615 0.011 to 0.040 .002
PreMax of Ab (mm)
Aorta .880
FL .434
PreMax of D (mm)
Aorta .173
FL .007
Complete thrombosis .340
CI, Confidence interval; HTN, hypertension; FL, false lumen; ICA, intercostal artery;
PreMax, preoperative maximal diameter; Ab, abdominal aorta; D, descending
thoracic aorta. *Beta co-efficiency (adjusted estimated) for linear regression analysis.
The Journal of Thoracic and CaFourth, a standardized reporting system does not exist,
including a lack of consensus regarding definitions of
clinical success and concerns about treatment failure.
Most reports have focused on FL thrombosis and have
relied on the arterial phase of CTA to determine the
treatment effect. However, FL can persist in the delayed
phase. The absence of contrast in the delayed phase does
not indicate thrombosis but denotes a low-flow state. In
the present study, we used both the arterial and 3-minute de-
layed phase; the delayed phase image altered the FL status
in 7 cases (35%) (Figure E2). As evident from these various
reports, the reasons for variation in the rates of complete FL
thrombosis arise from several sources of cohort heterogene-
ity. In our study, we aimed for greater patient homogeneity
to describe a universal outcome for patients with CDIIIb
aneurysms.
The possible mechanisms for persistent FL perfusion
include distal reentry tears, retrograde filling flows into
the FL, and motion of the dissection flap.11 The first mech-
anism suggests that reentry segments, distal to the stent
graft, can provide retrograde perfusion into the thoracic
FL and antegrade perfusion into the abdominal FL. Our
treatment strategy covers all tears in the descending
thoracic aorta to the celiac trunk level to accelerate
thrombus formation in the FL. However, this goal is difficult
to achieve, particularly in patients with multiple reentry
tears located in the abdominal aorta. Multiple tears are
commonly seen in CDIIIb aneurysms; 1 tear, distal to
the orifice of the celiac artery, was present in 62% of pa-
tients in 1 report,23 and an average of 2.8 intimal tears
was found in another series,24 allowing continued FL perfu-
sion after TEVAR. In the present study, the primary entryrdiovascular Surgery c Volume 148, Number 3 929
FIGURE 2. Results of univariate linear regression analysis showing prognostic factors significantly related to a decreased false lumen (FL) ratio. ICA,
Intercostal artery.
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of 3.1 tears (reentry tears, 2.0; large intimal tears, 1.1) re-
mained below the stent graft. The number of large intimal
tears found using CTA 4 weeks after TEVAR was selected
as a parameter for analysis and was a significant risk factor
associated with partial thrombosis in the FL (P ¼ .037).
The second mechanism proposes retrograde filling perfu-
sion of the FL by way of the ICAs or visceral branches orig-
inating from the FL. Visceral branches solely supplied by
the FL in extensive type B dissections were first emphasized
by Dinsmore and colleagues.25 They proposed that if vital
organs did not depend on the FL for their blood supply,
complete FL occlusion tended to occur. Others26 have re-
ported that the visceral branches that arose partially or
totally from the FL were risk factors for partial thrombosis
in acute DeBakey IIIb aortic dissection. To date, no report
has been published about ICAs affecting aorta remodeling.
The present study revealed that the number of visceral
branches and ICAs arising partially or totally from the FL
was an independent risk factor associated with FL
shrinkage (P¼ .002) at 4.7 month after TEVAR. The results
from our study suggested the first mechanism would affect
the early phase of aortic remodeling, and the second mech-
anism would affect aortic remodeling after the period.
Regarding the third mechanism, the role of intimal flap
motion was recently analyzed in another report.27 Unim-
peded septal motion could conceivably prevent flow stagna-
tion and thrombosis in the aortic FL. The present study
revealed the younger age was an important risk factor for
FL shrinkage 4.7 months after TEVAR (P ¼ .015). This
was because the elderly would have more restricted septal
motion than would younger patients.
With our TEVAR strategy for CDIIIb aneurysms, ex-
tending the stent graft to the level of the celiac trunk, all
reentry tears in the descending thoracic aorta were
completely covered. This strategy resulted in complete
FL thrombosis at the stent graft level in 13 patients930 The Journal of Thoracic and Cardiovascular Surg(65%) during a mean follow-up duration of 28 days.
Furthermore, FL thrombosis occurred more frequently in
patients with fewer residual reentry tears below the level
of the stent graft and in those with fewer ICAs and visceral
arteries from the FL. However, the level of the distal stent
graft was not associated with FL thrombosis or aorta re-
modeling. Although we expected the more distal landing
zone would result in more complete FL thrombosis, the
rate was only 37.5% in group 1 compared with 80% in
group 2 in our study (Table E1). This unexpected result
suggests that the level of the distal stent graft itself is not
associated with the FL thrombosis. Rather, the anatomic
factors such as the number of reentry tears, large intimal
tears, ICAs from the FL, and visceral branches from the
FL would be more important for the outcome after TEVAR
in patients with CDIIIb aneurysms.
Additional Concerns
The potential for endograft collapse, stent graft-induced
new intimomedial erosions, and retrograde aortic dissec-
tions are additional concerns regarding TEVAR manage-
ment of CDIIIb aneurysms.14 Despite the frequent
presence of small, distal, true lumens and rigid septa, we
did not observe endograft collapse, perhaps because we
used tapered grafts for the distal true lumens. Two patients
experienced new, stent graft-induced intimal tears. Exces-
sive oversizing of the distal stent graft could be a significant
risk factor with regard to late distal intimomedial erosion.28
After those cases, we stopped using excessive oversizing
and did not deploy stent grafts at the mid-descending
thoracic aorta level. Similarly, retrograde dissections, re-
ported in4% of other cases,14 did not occur in the present
series. These events underscore the limitations of the cur-
rent stent graft designs for chronic dissections. In most
cases, treatment extended to the left common carotid artery,
and the endograft must adapt to significant differences in
lumen diameters between the proximal and compressedery c September 2014
Song et al Acquired Cardiovascular Disease
A
C
Ddistal true lumens. The next generation of stent graft design
will likely have pathology-specific modifications to address
these challenges.29 The most dreaded complication of TE-
VAR for CDIII aneurysm management is SCI. When we
decide the level of distal landing zone, we should assess
the balance between the benefit of complete FL thrombosis,
and the risk of SCI. Although we aggressively manage
CDIIIb aneurysms at our institution, deploying the stent
grafts above the celiac trunk level, SCIs have not occurred.
Of note, we use a protocol involving liberal use of cerebro-
spinal fluid drainage and subclavian revascularization.
Study Limitations
The present report had several important limitations.
First, this was a single-center, retrospective analysis,
without an open surgical cohort for comparison. Regard-
less, open therapy could still be an attractive option for
selected patients. Svensson et al10 reviewed a contemporary
open surgical series involving elective descending thoracic
aortic aneurysm repair, including those attributed to chronic
dissection, and recommended open surgical repair only in
low-risk patients. Second, because of the lack of consensus
regarding the definition of clinical success and favorable
aortic remodeling, the present results might not be directly
comparable to other reports of TEVAR for CDIII aneu-
rysms. Mani and colleagues15 defined aorta remodeling as
a>0.5 cm reduction in the maximum descending thoracic
aorta diameter from preoperative imaging to the final
follow-up imaging study. However, we used the degree of
FL thrombosis and FL ratio as surrogate markers for aorta
remodeling. A consensus on more accurate classification
and definition could help to determine the most appropriate
method of treating chronic dissection in terms of the timing
and extent of aortic coverage.20 Third, the number of pa-
tients was very small, and the follow-up duration was too
short to draw conclusions regarding the aorta remodeling
process and survival analysis. However, we confirmed that
the period for FL thrombosis could be as short as 4 weeks
and that FL regression occurred at around 3 to 6 months af-
ter TEVAR. Fourth, although postoperative CTAwas avail-
able for all patients, only 2 points were analyzed to discern
FL thromboses and diameters. Moreover, multilevel and
volumetric data were not abstracted, which might have
offered a more comprehensive and precise assessment of
aortic remodeling for dissection-related pathologic fea-
tures.16 FL patency status was determined using the 3
phases of postoperative CTA, and this might may not be
the most sensitive or specific method for analyzing this
endpoint, given the reports describing the efficacy of
various dynamic magnetic resonance imaging techniques.27
CONCLUSIONS
TEVAR for CDIIIb aneurysms ensures a high degree of
technical success and results in acceptable perioperativeThe Journal of Thoracic and Camorbidity and mortality. SCI can be prevented with the lib-
eral use of spinal drainage and subclavian revascularization.
Although all reentry tears were fully covered above the ce-
liac trunk, the visceral branches and ICAs from the FL and
visible communicating channels below the celiac trunk will
keep the FL pressurized and are unfavorable prognostic
factors of aorta remodeling after TEVAR for CDIIIb
aneurysms.
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Dr John S. Ikonomidis (Charleston, SC). Congratulations on a
very interesting study that is advancing our knowledge about the
predictive factors for remodeling and FL thrombosis. I wonder if
you could reconcile a few issues for me.
You defined partial thrombosis as a situation in which both flow
and thrombus are present in the FL, but I wonder whether this is a
specific enough definition. I wonder if you would comment on
exactly what you mean by flow. For example, from the CT scans
that you have, if you see a patient with a simple type I endoleak,
are you defining that as flow?
Dr Song. Yes. Thank you for your comments, Dr Ikonomidis.
Regarding the FL status, if some contrast is present in the FL
with the arterial phase or delayed phase, we regard the status of
the FL as partial thrombosis. If we cannot find any contrast in
the arterial phase and delayed phase, we regard it as complete
thrombosis.
In other words, we regard the contrast as flow. But the CTA
might not be the most sensitive or specific method for analyzing932 The Journal of Thoracic and Cardiovascular Surgthis endpoint given the reports about various dynamic magnetic
resonance imaging techniques.
Also, in our study, no type Ia endoleaks occurred. Thus, the FL
will be thrombosed from top to bottom. I think that immediately
after TEVAR, antegrade flow or retrograde flow is always present
to the FL in the distal part. If it has not disappeared at the latest sur-
veillance scan, it can be classified as partial thrombosis.
Dr Ikonomidis. Thank you. Second, in the Gangnam TEVAR
registry, you identified 20 of 103 patients who had undergone elec-
tive TEVAR. How many patients in that registry had chronic type
B dissections that were not included in this analysis from that reg-
istry? Also, did they undergo stent grafting, or, if not, what was the
reason that they were not included?
Dr Song.Yes. The Gangnam TEVAR registry identified 103 pa-
tients who had undergone elective TEVAR within a 1-year period.
Among those, about 40 patients had a degenerative aortic aneu-
rysm, 30 had acute type B aortic dissection, and 10 had traumatic
dissections.
Also, we are following up many patients with chronic type B
dissection by ourselves, and if the aneurysm expands>5.5 cm or
the growth rate is>5 mm in 6 months or if newly developed
back pain or continuous pain or malperfusion is present, that is
an indication for elective TEVAR.
Also, during this study period, 4 patients underwent surgical
repair of the thoracoabdominal aorta. All these patients were
very young or had some connective tissue disease or concomitant
enlargement of a dissecting aneurysm at the abdominal aorta.
Dr Ikonomidis. Thank you. My last question pertains to the
report, in which you state that in all patients, full coverage of the
descending thoracic aorta was achieved. However, in this partic-
ular study, it becomes apparent that there was progression in the
distal landing zone, first in the mid-descending thoracic aorta
and progressing distally such that in some patients juxtaceliac
coverage was present.
Could you comment on the differences in the distal landing
zone and did that happen as a result of the anatomy that you saw
or as the result of a progressive change in your selection of the
distal landing zone?
Dr Song. Yes. I apologize that I have made some confusion for
you, but our basic principle for TEVAR for the patient with a
complicated type IIIb aortic aneurysm is to cover all the visible
communicating channels at the descending thoracic aorta.
For the 2 patients in group 3 whose distal landing zone was at
the mid-descending thoracic aorta, no visible tears were seen on
a CTA at the distal part of the descending thoracic aorta.
We experienced new intimal tears at the end of the stent graft in
the 2 patients. After that case, we decided not to deploy any more
stents at the mid-descending thoracic aorta level but to cover the
whole descending thoracic aorta and treat down to just above the
celiac trunk. It was our intent to cover all the visible and invisible
communicating channels, if possible.
Dr Ikonomidis. Thank you very much, and, once again, con-
gratulations for a nicely performed and presented study.
Dr Song. Thank you.
Dr HishamM. F. Sherif (Newark, Del). I have no financial dis-
closures. Thanks very much for your nice presentation.
You state that one of the reasons for aortic remodeling is persis-
tence of intercostal segmental artery flow, which technically con-
stitutes a type II endoleak.ery c September 2014
Song et al Acquired Cardiovascular DiseaseMy 2 questions are, first, at the time of deployment of the en-
dograft, was that recognized, and if so, was it addressed at the
time? Also, if it has not been addressed, are you planning to
follow-up on this endoleak with another study to see whether other
measures have eliminated it or not?
Dr Song. Thank you for your excellent questions. However,
very few reports have been published about type II endoleaks for
chronic type III aortic dissections.
In a case with acute type B dissections, 1 study commented
on the visceral branches for the backflow from the visceralThe Journal of Thoracic and Cabranch to the FL. However, as far as I know, no report has
yet been published about ICAs from the FL that make retrograde
backflow to fill the FL and prevent FL thrombosis. I think it is
very difficult to know if a type II endoleak from the ICAs is
present at intervention. Also, I cannot tell you about the type
II endoleak, which is a terminology frequently used with the
degenerative aneurysm, because the pathologic features are
clearly different between chronic IIIb aneurysm and degenera-
tive aneurysm.
Dr Sherif. Thanks for the presentation.rdiovascular Surgery c Volume 148, Number 3 933
A
C
D
TABLE E1. Distal landing zone
Variable Group 1 (n ¼ 8) Group 2 (n ¼ 10) Group 3 (n ¼ 2) P value
Spinal drainage 8 (100) 5 (50) 0 (0) .006
Reentry 2.1  1.4 1.9  1.8 1.5  0.7 .874
Large intimal tear 1.4  0.9 0.9  0.6 1.0  1.4 .462
ICAs from FL 5.1  3.4 3.4  2.6 5.0  4.2 .477
Visceral branches from FL 1.6  1.1 1.6  1.1 1.5  0.7 .989
FL ratio 0.74  0.14 0.76  0.14 0.76  0.13 .902
Complete thrombosis 3 (37.5) 8 (80) 2 (100) .147
Data presented as n (%) or mean  standard deviation. ICA, Intercostal artery; FL, false lumen.
FIGURE E1. Aortic remodeling analysis using preoperative and postoperative computed tomography angiograms (CTAs). A, Axial view of the preoper-
ative CTA. B, Axial view of the postoperative CTA. a, Maximal diameter of the false lumen on the preoperative CTA; b, maximal diameter of the false lumen
on the postoperative CTA.
FIGURE E2. Alteration of false lumen thrombosis according to the phase of the postoperative computed tomography angiogram (CTA). A, Axial view of
the CTA showing complete thrombosis in the arterial phase. B, Axial view of the CTA, at the same level, showing partial thrombosis in the delayed phase.
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